SCHEMBL10567329

SCHEMBL10567329

Cc1cc2c(cc1[S+](C)[O-])CCNCC2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADCY6 O43306 1/20 0.41
▸ ADCY3 O60266 1/20 0.41
▸ ADCY9 O60503 1/20 0.41
▸ ADCY5 O95622 1/20 0.41
▸ ADCY8 P40145 1/20 0.41
▸ ADCY7 P51828 1/20 0.41
▸ ADCY2 Q08462 1/20 0.41
▸ ADCY1 Q08828 1/20 0.41
▸ ADCY4 Q8NFM4 1/20 0.41
▸ HTR2C P28335 11/20 0.36
▸ HTR2B P41595 9/20 0.36
▸ HTR2A P28223 2/20 0.36
▸ MLNR O43193 1/20 0.32
▸ DRD2 P14416 2/20 0.31
▸ DRD1 P21728 1/20 0.31
▸ ASIC3 Q9UHC3 1/20 0.31
▸ CD274 Q9NZQ7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10350476 0.98 ADCY6 (0.39) ADCY6ADCY3ADCY9ADCY5ADCY8
SCHEMBL10563469 0.80 ADCY5 (0.59) ADCY6ADCY3ADCY9ADCY5ADCY8
SCHEMBL10564212 0.80 HTR2C (0.43) ADCY6ADCY3ADCY9ADCY5ADCY8
Hydrochloric Acid SCHEMBL10350885 0.79 ADCY5 (0.57) ADCY6ADCY3ADCY9ADCY5ADCY8
Hydrochloric Acid SCHEMBL10564211 0.79 HTR2C (0.42) ADCY6ADCY3ADCY9ADCY5ADCY8
SCHEMBL11742860 0.77 ADCY6 (0.56) ADCY6ADCY3ADCY9ADCY5ADCY8
Hydrochloric Acid SCHEMBL10350543 0.76 HTR2C (0.54) ADCY6ADCY3ADCY9ADCY5ADCY8
SCHEMBL10564473 0.70 HTR2C (0.48) ADCY6ADCY3ADCY9ADCY5ADCY8
Hydrochloric Acid SCHEMBL10351372 0.69 HTR2C (0.47) ADCY6ADCY3ADCY9ADCY5ADCY8
SCHEMBL6304719 0.68 HTR2C (0.50) ADCY6ADCY3ADCY9ADCY5ADCY8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824839-A Sulfinyl and sulfonyl substituted 2,3,4,5 tetrahydro-1H-3-benzazepines and their use in treating gastrointestinal motility disorders SMITHKLINE BECKMAN CORPORATION (US) 1989-04-25 — — US disclosed
Send feedback